Literature DB >> 34079036

Clinical features and prognostic factors in spinal meningioma surgery from a multicenter study.

Kazuyoshi Kobayashi1, Kei Ando2, Tomohiro Matsumoto3, Koji Sato4, Fumihiko Kato3, Tokumi Kanemura5, Hisatake Yoshihara6, Yoshihito Sakai7, Atsuhiko Hirasawa8, Hiroaki Nakashima2, Shiro Imagama2.   

Abstract

Meningiomas are benign tumors that are treated surgically. Local recurrence is likely if the dura is preserved, and en bloc tumor and dura resection (Simpson grade I) is recommended. In some cases the dura is cauterized and preserved after tumor resection (Simpson grade II). The purpose of this study was performed to analyze clinical features and prognostic factors associated with spinal meningioma, and to identify the most effective surgical treatment. The subjects were 116 patients (22 males, 94 females) with spinal meningioma who underwent surgery at seven NSG centers between 1998 and 2018. Clinical data were collected from the NSG database. Pre- and postoperative neurological status was defined using the modified McCormick scale. The patients had a mean age of 61.2 ± 14.8 years (range 19-91 years) and mean symptom duration of 11.3 ± 14.7 months (range 1-93 months). Complete resection was achieved in 108 cases (94%), including 29 Simpson grade I and 79 Simpson grade II resections. The mean follow-up period was 84.8 ± 52.7 months. At the last follow-up, neurological function had improved in 73 patients (63%), was stable in 34 (29%), and had worsened in 9 (8%). Eight patients had recurrence, and recurrence rates did not differ significantly between Simpson grades I and II in initial surgery. Kaplan-Meier analysis of recurrence-free survival showed that Simpson grade III or IV, male, and dural tail sign were significant factors associated with recurrence (P < 0.05). In conclusion, Simpson I resection is anatomically favorable for spinal meningiomas. Younger male patients with a dural tail and a high-grade tumor require close follow-up. The tumor location and feasibility of surgery can affect the surgical morbidity in Simpson I or II resection. All patients should be carefully monitored for long-term outcomes, and we recommend lifelong surveillance after surgery.

Entities:  

Year:  2021        PMID: 34079036     DOI: 10.1038/s41598-021-91225-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

1.  Descriptive Epidemiology of Spinal Meningiomas in the United States.

Authors:  Varun R Kshettry; Jason K Hsieh; Quinn T Ostrom; Carol Kruchko; Edward C Benzel; Jill S Barnholtz-Sloan
Journal:  Spine (Phila Pa 1976)       Date:  2015-08-01       Impact factor: 3.468

2.  Risk of brain tumors associated with exposure to exogenous female sex hormones.

Authors:  Annette Wigertz; Stefan Lönn; Tiit Mathiesen; Anders Ahlbom; Per Hall; Maria Feychting
Journal:  Am J Epidemiol       Date:  2006-07-11       Impact factor: 4.897

Review 3.  Spinal meningiomas: review of 174 operated cases.

Authors:  C L Solero; M Fornari; S Giombini; G Lasio; G Oliveri; C Cimino; F Pluchino
Journal:  Neurosurgery       Date:  1989-08       Impact factor: 4.654

4.  Complication avoidance in the resection of spinal meningiomas.

Authors:  Harrison J Westwick; Sung-Joo Yuh; Mohammed F Shamji
Journal:  World Neurosurg       Date:  2014-12-17       Impact factor: 2.104

5.  Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients.

Authors:  A Helseth; S J Mørk
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

6.  Effects of sex on the incidence and prognosis of spinal meningiomas: a Surveillance, Epidemiology, and End Results study.

Authors:  Harrison J Westwick; Mohammed F Shamji
Journal:  J Neurosurg Spine       Date:  2015-05-29

7.  Complications and outcomes of surgery for spinal meningioma: a Nationwide Inpatient Sample analysis from 2003 to 2010.

Authors:  Sudheer Ambekar; Mayur Sharma; Sunil Kukreja; Anil Nanda
Journal:  Clin Neurol Neurosurg       Date:  2014-01-03       Impact factor: 1.876

8.  Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007.

Authors:  Linh M Duong; Bridget J McCarthy; Roger E McLendon; Therese A Dolecek; Carol Kruchko; Lynda L Douglas; Umed A Ajani
Journal:  Cancer       Date:  2012-01-03       Impact factor: 6.860

9.  Spinal cord meningioma.

Authors:  W J Levy; J Bay; D Dohn
Journal:  J Neurosurg       Date:  1982-12       Impact factor: 5.115

Review 10.  EANO guidelines for the diagnosis and treatment of meningiomas.

Authors:  Roland Goldbrunner; Giuseppe Minniti; Matthias Preusser; Michael D Jenkinson; Kita Sallabanda; Emmanuel Houdart; Andreas von Deimling; Pantelis Stavrinou; Florence Lefranc; Morten Lund-Johansen; Elizabeth Cohen-Jonathan Moyal; Dieta Brandsma; Roger Henriksson; Riccardo Soffietti; Michael Weller
Journal:  Lancet Oncol       Date:  2016-08-30       Impact factor: 41.316

View more
  3 in total

1.  Minimally Invasive Tubular Retractor Surgery for Intradural Extramedullary Spinal Tumor Reduces Postoperative Degeneration of Paraspinal Muscle.

Authors:  Zhexi He; Cho Ying Li; Calvin Hoi-Kwan Mak; Tat Shing Tse; Fung Ching Cheung
Journal:  Asian J Neurosurg       Date:  2022-07-06

2.  MAC-spinal meningioma score: A proposal for a quick-to-use scoring sheet of the MIB-1 index in sporadic spinal meningiomas.

Authors:  Johannes Wach; Motaz Hamed; Tim Lampmann; Ági Güresir; Frederic Carsten Schmeel; Albert J Becker; Ulrich Herrlinger; Hartmut Vatter; Erdem Güresir
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

3.  Functional Outcome in Spinal Meningioma Surgery and Use of Intraoperative Neurophysiological Monitoring.

Authors:  Christopher Marvin Jesse; Pablo Alvarez Abut; Jonathan Wermelinger; Andreas Raabe; Ralph T Schär; Kathleen Seidel
Journal:  Cancers (Basel)       Date:  2022-08-18       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.